Chile - Country Profile
The Health in the Americas+ country profiles are based on the interagency indicators available as of the dates referenced. In some cases, the values of the indicators may differ from the most recent data available in the country.
Environmental and social determinants of health
In 2000 the total population of Chile was 15 503 635 inhabitants; by 2024 this figure had risen to 19 764 771, representing a 27.5% increase. Regarding the country’s demographic profile, in 2024 people over 65 years of age accounted for 14.1% of the total population, an increase of 6.0 percentage points compared to the year 2000. In 2024, there were 101.2 women per 100 men and 83.3 older people (65 years or older) per 100 children under 15 years of age, as can be seen in the country’s population pyramids, distributed by age group and sex (Figure 1). Considering the population between 15 and 64 years of age to be potentially active (i.e., potential participants in the labor force), this group represented 68.9% of the total population of the country in 2024 (13 617 681 people). When we add these figures to the potentially passive population (3 353 324 under 15 years of age and 2 793 768 over 65 years of age), the result is a dependency ratio of 45.1 potentially passive people per 100 potentially active people. This ratio was 53.8 in 2000.
Life expectancy at birth in 2024 was 81.4 years, higher than the average for the Region of the Americas and 4.3 years higher that in 2000 (77.1).
Figure 1. Population pyramids of Chile, years 2000 and 2024
Between 2004 and 2017, the average number of years of schooling in Chile increased by 9.1%, reaching an average of 10.6 years in the latest year for which information is available. The unemployment rate in 2023 was 9.1%. Disaggregated by sex, the rate was 9.5% for women and 8.8% for men. The literacy rate was 99.3% in 2022. In men, this figure was 99.5%; in women, 99.1%. In addition, 6.5% of the population were below the national poverty line in 2022, a decrease from 36% in 2000. In 2022, 0.4% of the population was living in poverty, defined as the percentage of the population with an income of less than US$ 2.15 per day; this is below the regional average of 2.6%.
During the period 2000-2022, the country improved its score on the Human Development Index, with an increase of 12.7% (from a score of 0.763 to a score of 0.86); during the same period, the index rose 14.6% internationally and 11.2% in Latin America (Figure 2).
Figure 2. Human Development Index in the Region of the Americas, 2022
In 2022, public expenditure on health accounted for 4.92% of gross domestic product (GDP) (Figure 3) and 18.54% of total public expenditure, while out-of-pocket spending on health accounted for 29.79% of total health expenditure.
Figure 3. Domestic general government health expenditure as percentage of gross domestic product, 2021
Digital coverage
In 2021, 90.2% of the population had an internet connection, representing a considerable increase from 2000, when 16.6% of the population had an internet connection.
Health situation
Maternal and child health
Between 2000 and 2020, infant mortality in Chile decreased from 8.9 to 5.6 deaths per 1000 live births, a decrease of 37.1% (Figure 4). The percentage of low-weight births (less than 2500 g) increased from 5.3% to 6.7% between 2000 and 2020.
Regarding the immunization strategy, measles vaccination coverage was 94.0% in 2022, a decrease of 3.0 percentage points from 2000.
Figure 4. Infant mortality per 1000 live births, 1995–2021
The maternal mortality ratio in 2020 was estimated at 15.0 deaths per 100 000 live births, representing a 53.8% reduction compared to the estimated value in 2000 (Figure 5). In relation to fertility, it is estimated that in 2024 women had an average of 1.1 children throughout their reproductive lives. In the specific case of adolescent fertility, there was a 90.8% decrease, from 61.2 live births per 1000 women aged 15 to 19 years in 2000 to 5.6 in 2024. In 2020, 99.9% of births were attended by skilled birth personnel.
Figure 5. Maternal mortality per 100 000 live births, 2000–2020
Communicable diseases
In 2022, there were 15 new cases of tuberculosis per 100 000 population in Chile. In 2019, the overall tuberculosis mortality rate (age-adjusted and per 100 000 population) was 1.5 (1.0 in women and 2.2 in men).
In 2021, the estimated human immunodeficiency virus (HIV) infection incidence rate (new diagnoses) was 25.9 per 100 000 population. The age-adjusted mortality rate for HIV was 2.5 per 100 000 population in 2019. It should be noted that during the 2000-2019 period this indicator decreased by 17.1%.
Noncommunicable diseases and risk factors
In Chile in 2023, the prevalence of tobacco use among people aged 15 and older was 27.2%. In the same age group, the prevalence of overweight and obesity was 78.8% in 2022.
Also in 2016, 26.6% of the population reported insufficient physical activity.
In 2015, the reported prevalence of arterial hypertension (high blood pressure) among people aged 18 years or older was 20.9%, a decrease of 5.8 percentage points compared to 2000 (26.7%). The prevalence of diabetes mellitus, which stood at 8.7% in 2000, increased to 10.5% in 2014.
Mortality
In 2019, the adjusted rate of potentially avoidable premature mortality in Chile was 139.1 deaths per 100 000 population, a decrease of 30.6% compared to the rate of 200.3 in 2000. This meant that in 2019 the rate in the country was 38.6% lower than the average rate reported for the Region of the Americas as a whole. Among potentially preventable premature deaths, the rate for preventable causes was 79.1 per 100 000 population in 2019, which is 42.3% lower than the regional average rate; and the rate for treatable causes was 60 per 100 000 population, below the regional average of 89.6.
The overall age-adjusted mortality rate was 4 per 1000 population in 2019, a decrease of 29.8% compared to 2000 (5.7 deaths per 1000 population).
When deaths are categorized into three main groups, it is observed that, in 2019, the age-adjusted mortality rate from communicable diseases was 29.5 per 100 000 population (36.7 per 100 000 in men and 23.6 per 100 000 in women), while the age-adjusted mortality rate from noncommunicable diseases was 328.9 per 100 000 population (403.8 per 100 000 in men and 271.2 per 100 000 in women). The rate of age-adjusted mortality from external causes was 38.4 per 100 000 population (61.2 per 100 000 in men and 16.6 per 100 000 in women), including road traffic accidents (13.5 per 100 000 population), homicides (3.9 per 100 000 population), and suicides (8 per 100 000 population). In 2000, the percentage distribution of causes was 79.1% for noncommunicable diseases, 10.9% for communicable diseases, and 10.1% for external causes; in 2019, the percentages were 85.1%, 7.1%, and 7.8%, respectively (Figure 6).
Figure 6. Proportional mortality in Chile, 2000 and 2019
Cancer mortality
Regarding cancer mortality from tumors, in 2019 the adjusted mortality rate from prostate cancer was 20.2 per 100 000 men; lung cancer, 17.4 per 100 000; and colorectal cancer, 12.8 per 100 000. In women, these values were 11.8 deaths per 100 000 for breast cancer; 9.3 per 100 000 for lung cancer; and 9.7 per 100 000 for colorectal cancer.
Health in the Americas: On the Road to Disease Elimination in Chile
In the following text, the Ministry of Health of Chile provides detailed and specific national information for the topics Health Situation and the Diseases of the Elimination Initiative and the National Perspective. Special emphasis is placed on how actions are being addressed locally to promote the elimination of communicable diseases.
Perspectives
Below are local perspectives from the country, offering forward-looking statements on the country's health priorities, with a focus on the Elimination Initiative.
Achievements in Disease Elimination
Chile is well-positioned to demonstrate that it has eliminated leprosy, human rabies transmitted by dogs, yaws, and vertical transmission of HIV/syphilis/hepatitis B. With additional efforts, it can accelerate the elimination of viral hepatitis, Chagas disease including vertical transmission, cervical cancer, and cystic echinococcosis/hydatidosis, and advance towards elimination goals for tuberculosis, HIV/AIDS, sexually transmitted infections, and bacterial meningitis. To achieve this, the country is moving decisively towards universal health coverage based on primary care and universal and free access, as a basic pillar of equity and resilience. Within this framework, the Elimination Initiative contributes to making more efficient use of resources, reaching the most vulnerable populations, achieving integrated and comprehensive care services, reducing health inequities, and accelerating the achievement of goals, improving the well-being of individuals and their communities.
To date, the country has reached milestones to certify the elimination of canine rabies, leprosy, yaws, and mother-to-child transmission of HIV, syphilis, and hepatitis B. All of these diseases are subject to epidemiological surveillance with mandatory reporting. In terms of Human Rabies transmitted by dogs (canine rabies), Chile has not had any indigenous cases since 2013. The last reported case in Chile did not result in death. To certify elimination, the indicator of deaths from rabies transmitted by dogs per 1,000 inhabitants must be maintained at zero. Regarding Leprosy or Hansen's Disease, there have been no indigenous cases in Chile for over 20 years. It has been described that in the past, only Easter Island had indigenous cases. Between 2001 and 2023, a total of 53 cases of leprosy have been confirmed in Chile, all imported. The 2021-2030 National Health Strategy, in its impact objective 1.4, states that zero indigenous cases of vector-borne and zoonotic diseases are expected to be maintained.
Chile is committed to achieving the goals of the ETMI Plus initiative, which aims to achieve and maintain the elimination of mother-to-child transmission of HIV, syphilis, Chagas disease, and perinatal hepatitis B virus (HBV) infection as public health threats. The country adheres to the principles and lines of action of the Strategy for Universal Access to Health and Universal Health Coverage and leverages the lessons learned from the Strategy and Action Plan for the Elimination of Mother-to-Child Transmission of HIV and Syphilis, from 2010. Current figures show that the country is approaching the elimination goals of these diseases: it has a mother-to-child HIV transmission rate of 1.80% (2021), with the elimination target being less than 2%; while the congenital syphilis rate is relatively low (0.41 per 1,000 live births), with the target being to keep the indicator below 0.5 per 1,000 live births. For Chagas disease, the mother-to-child transmission rate is 0.145%, although the goal is for 90% of cases to be diagnosed, treated, and monitored, which was not achieved in Chile during the previous decade. For hepatitis C, incidence rates have been decreasing, reaching 1.7 cases per 100,000 in 2021, but the goal is to reduce the incidence by 90% compared to 2015.
Efforts to address cervical cancer date back to 1987 when the Cervical Cancer Prevention and Control Program was established, with Pap smears and the training of involved personnel as central components. In 2004, this disease was one of the first to be included in Law 19,966, guaranteeing access, opportunity, financial protection, and quality of screening, diagnosis, treatment, and follow-up. In 2014 and 2019, the quadrivalent HPV vaccine was incorporated into the National Immunization Program (PNI) for girls and boys, respectively. The scheme was modified in 2024 to a single-dose nonavalent vaccine. Additionally, Chile is one of the Member States that has adopted the Global Strategy for the Elimination of Cervical Cancer as a public health problem, which presents significant challenges in molecular screening. In this context, by 2022, the age-adjusted incidence rate for cervical cancer in Chile was estimated at 11.3 per 100,000 women, with an age-adjusted mortality rate of 4.5 per 100,000 women.
Current Efforts and Roadmap to 2030
The technical teams of the various departments, divisions, and programs of the Ministry of Health, as well as their authorities, have recognized the country's potential to join the Elimination Initiative by leveraging its capacity, the history of achievements, and the commitment to continue advancing towards the elimination goals of these diseases. Thus, the country has proposed to demonstrate, through formal validation and certification processes, that it has reached these goals. This represents an opportunity to showcase the impact results to national and international public opinion and position the Ministry of Health at the forefront of achievement, encouraging national and subnational technical teams to continue making progress. This will help mobilize national and regional government resources to accelerate efforts in diseases where there have been encouraging advances and promising results in the medium term, such as the elimination of cervical cancer, viral hepatitis, Chagas disease including vertical transmission, tuberculosis, HIV/AIDS, sexually transmitted infections, cystic echinococcosis and hydatidosis, bacterial meningitis, yellow fever, among others.
To achieve this, as well as other objectives, the Ministry of Health has a National Health Strategy for the decade. Within its Strategic Objectives, number 1 focuses on Communicable Diseases. This objective includes specific goals such as reducing the incidence of HIV/AIDS; reducing the incidence of tuberculosis; reducing morbidity and mortality from acute respiratory infections; reducing the incidence of zoonotic and vector-borne diseases, where coordination is made with other technical departments and the intersector to apply the "One Health" principle to address neglected diseases that will be incorporated into the action plan for their elimination, and lastly, reducing the risk of reintroduction or increase of Communicable Diseases on the path to Elimination. In particular, regarding the last goal, feasible interventions can be implemented to advance the elimination of the mentioned diseases, using existing tools and technologies. There is integrated work between the Department of Epidemiology, the National Immunization Program, and the national reference laboratory, the Public Health Institute. For both measles and rubella, Chile has been reverified in its elimination status, and for polio, it was ratified in 2024 by PAHO as a low-risk country for importation, along with Colombia, the only two countries in South America with this status.
Regarding cervical cancer and within the framework of Law 19,966, as the Ministry of Health, we are in the process of evaluating the incorporation of HPV molecular testing for the age range of 35 to 45 years and other modifications related to this guarantee regime to achieve the goals associated with the global elimination strategy.
The country is currently developing a strategic plan with elimination goals for the considered diseases, including a roadmap until 2030.
Challenges and Gaps Regarding the Strategic Action Lines of the Elimination Initiative
For the country to continue advancing on the path to eliminating communicable diseases, it is essential to formulate an Action Plan that establishes strategic actions aligned with the Ministry of Health's priorities to contribute to strengthening health systems and services with an emphasis on primary health care and building resilient systems, strengthening information and surveillance systems, advancing social and environmental determinants, and reinforcing governance, stewardship, and financing. The Roadmap will be able to target elimination goals in prioritized territories according to their specific characteristics, progressing in decentralization. This Roadmap will allow the Ministry of Health to demonstrate early successes in diseases where the country has already reached indicators such as human rabies transmitted by dogs (Chile could be the second country in the world to demonstrate the elimination of this disease), leprosy (Chile could be the first country in the Region to apply the criteria to eliminate leprosy), vertical transmission of HIV/syphilis/hepatitis B (Chile could complete the evidence and be one of the first continental countries to reach the goal, joining the list of Caribbean countries that have already achieved it), and yaws (Chile could be the first country without a history of yaws in the Region to complete the certification process and declare itself free of the disease).
A challenge related to the integration of health systems and services is strengthening the elimination program in Primary Health Care, identifying the social determinants of its community, with territorial, cultural, and temporal relevance, from a multi-disease approach. This requires network planning with guaranteed resource allocation. An opportunity is the basic health reform plan in Universal PHC, which is currently under development.
From a programmatic perspective, expanding universal or targeted screenings by territory or risk group for diseases on the path to elimination is an opportunity to improve detection and control. This requires increased funding for the implementation of this Strategy. Likewise, inter-ministerial collaboration should be promoted, which must be sustainable over time and involve the participation of the highest authorities of the convened bodies.
Regarding the strengthening of health surveillance and information systems, they must advance towards integration and interoperability, depending on the needs of each disease, centered on people. The advances in health intelligence, and putting it at the service of this agenda, are a challenge. Chile has progressed with the law on electronic health record interoperability, which is a step forward in this agenda, but it is necessary to strengthen the information and communication technology (ICT) units of the Ministry of Health of Chile (MINSAL) and the Health Services, with the expansion of resources that allows it.
System integration must be a shared responsibility, especially in a context of multiple tasks. Service contracts should consider its maintenance and advance towards a single database, ideally with a long-term electronic medical record (EMR). Regarding the EMR, there will be multiple records, with a minimum set of data shared across different records and MINSAL. It is crucial that the minimum data set goes beyond sociodemographic data, considering the milestones of each disease's processes.
To strengthen health surveillance, one key challenge is keeping technical standards and plans updated to implement strategies for disease management that were postponed during the pandemic. In addition, continuous training of teams in alert and response is essential to deliver timely responses to health emergencies. Finally, ensuring adequate funding sources for outbreak control is another significant challenge, as a lack of resources can limit the capacity to address and control diseases.
Regarding the addressing of environmental and social determinants of health, it is necessary to level the visibility of these diseases concerning others, through various mechanisms that allow increased community knowledge of these diseases, as well as strategies for their identification and control. Mostly, communicable diseases share a significant burden expressed in mortality and morbidity, accompanied by stigmatization, which is disproportionately expressed in rural or marginalized communities. In this sense, adopting comprehensive approaches to cervical cancer promotion and prevention related to access to education and information about the risk factors for this disease, access to immunization programs, screening, and treatments can reduce the risk of developing this disease.
The information integrated into the information systems will allow the identification of the population at greater risk and the implementation of targeted actions for their control. Currently, interventions for HIV control have shown good results, in relation to the penitentiary system, among others. Particularly in neglected diseases such as leprosy or yaws, there is a lack of community participation, opinion leaders, and other non-governmental organizations. There is an opportunity to raise awareness in the community about early symptoms, screening, and control mechanisms, and not just for health professionals through Notifiable Diseases.
In this regard, establishing indicators based on the "One Health" framework and the "Sustainable Development Goals" will help develop a regulatory framework that promotes and facilitates agreements in the context of diseases on the path to elimination.
Finally, for all this to be effective, the elimination initiative must be a State policy, centered on people, with fixed resources and legal linkage, with coordinated intersectoral work, and the involvement of civil society. All of this implies the strengthening of governance for the initiative, which must be sustainable and consistent with inter-program synergy to allocate resources efficiently.
Public-private partnerships offer the opportunity to improve the visibility of diseases, as long as governance remains with the State. Identifying key actors will allow identifying territorial gaps and strategic collaborators such as regional governments, especially in terms of intersectoral alliances for achieving the objectives of this agenda.
Looking ahead, the next steps for the Ministry of Health are:
- To formulate the Roadmap for the elimination of communicable diseases in Chile, which includes agreeing on the list of diseases to be included according to MINSAL's priorities.
- To manage the construction process of this Roadmap to facilitate the synergistic work of the technical groups of the two Subsecretariats, Public Health and Health Networks, ensuring an approach from the universalization of primary health care and the support of the highest level to expedite the process.
- To carry out a joint mission in the country with PAHO regional advisors and MINSAL technical teams to identify, based on their Roadmap, opportunities for improvement and integration, technological innovations and service delivery models, and critical actions at the policy, management, and service levels to address priority communicable diseases in an integrated, efficient, and sustainable manner, and accelerate progress toward their elimination.
- To request support from international cooperation with PAHO/WHO for training in the certification process for diseases in which the country has reached elimination thresholds.
Addressing Equity in the Elimination Initiative Efforts
Primary Health Care (PHC) is the platform on which efforts to eliminate communicable diseases rest. The Ministry of Health continuously works to safeguard the equitable distribution of this initiative's strategies across the national territory, through financing that includes equity adjustments, a concern for effective access with measurements of intermediate and final results, special incentives to ensure the availability of health personnel in disadvantaged areas, such as the program for doctors in the training stage and then assigned according to the needs of the territories, or salary incentives for municipal personnel adjusted by performance demand, isolation, etc. Our latest efforts are summarized in the Universal PHC reform project, where a series of measures are implemented to achieve effective access for the entire population, along with the integration of social care into health.
Health issues such as HIV; Hepatitis B and C, cervical cancer are included in the Explicit Health Guarantees (GES) regime, ensuring screening, diagnosis, and follow-up of these diseases for the population with public and private health insurance.
The Public Health Programs for Tuberculosis, STIs, and Chagas are national programs with universal coverage and completely free for all people who need them, regardless of the health system they belong to and their migration status.
A solid risk communication program focused especially on the vulnerable population needs to be advanced, forming community leaders and promoting community participation in the identification and management of these diseases. It is also necessary to adopt an intersectoral approach, collaborating with sectors that influence the prevalence and management of these diseases, such as education, water, and sanitation, and the economic sector. Finally, we can contribute to implementing mechanisms to monitor and evaluate the impact of interventions on equity, which will allow strategies to be adjusted and ensure that efforts effectively reduce inequalities in access and management of these diseases.
Community and Civil Society Participation Strategies
In the agenda for the prevention, control, and elimination of Hepatitis, the Ministry of Health maintains a working relationship with the Hepatitis Patients Foundation (FUPAHEP), which is part of the advisory committee on this health issue and acts as an amplifier of the strategies implemented for the screening and treatment of this disease.
For the control of Chagas disease transmission, there is a civil society and academic organization called "Chao Chagas Chile," which provides knowledge about the challenges of Chagas for Chile, associated with migration, territory, and access to rights in a qualitative manner to the care dynamics of this disease, in the regions of Tarapacá, Atacama, and Metropolitana. They provide information for health teams and the general community.
Regarding Cervical Cancer, Cancer Law 21.258 establishes the participation of patient foundations or organizations through the formation of the National Cancer Commission, which in turn is linked in the exercise of its functions to positioning cancer in different governmental sectors, making recommendations, supporting the implementation of the National Cancer Plan, advising the Ministry of Health on regulations, plans, and programs for the prevention, surveillance, screening, and control of cancer, such as cervical cancer.
For HIV/AIDS and Sexually Transmitted Infections (STIs), social participation and the strengthening of community leadership constitute a central axis in the development of the National Plan for the Prevention and Control of these diseases. Within the framework of Law 19,779 on AIDS and Law 20,500 on Citizen Participation, the Ministry of Health carries out different social participation initiatives during the process of defining plans, strategies, and formulating specific regulations and interventions. In this regard, Organized Civil Society has been involved in the country's response to HIV/AIDS and other STIs since 1987 with the creation of the first NGO, National AIDS Prevention Corporation, currently "Acción Gay," to which more than 100 organizations nationwide have joined, implementing multiple initiatives in various areas of action: community prevention, condom distribution, access to rapid visual testing, development, and distribution of educational materials on safe sex and STI prevention, involvement in the design, implementation, and evaluation of public policy, social communication actions (national HIV campaign), among others. This participation is expressed both at the central level in its connection with the Ministry of Health and at the decentralized level, forming part of the Regional Integrated Response, led by Regional Health Authorities. The National Program for the Prevention and Control of HIV/AIDS and STIs Department, responding to the needs identified and raised by social organizations for better involvement and joint work in the response to HIV and other STIs in the country, is currently working on the design of a new social participation mechanism that is in line with the new Strategic Plan of the National Program 2024 – 2030.
Finally, as a good practice, we highlight the local strategy of the School of Managers for the prevention of hydatidosis. It is an initiative of the Zoonoses and Vectors Office in collaboration with Health Promotion. This initiative aims to train, raise awareness, and promote in communities with the highest incidence of hydatidosis, measures to protect the population's health. Relevant social actors in the municipalities are provided with tools to replicate information about the disease and how to prevent it.
Country Coordination Mechanisms for Disease Elimination
Including these diseases on the path to elimination in the National Health Strategy allows us to establish common efforts from the different technical departments to address this goal. This should translate into an integrated plan with the various technical areas involved to strengthen them and improve current indicators. In particular, for zoonotic diseases, it is essential to strengthen integration under the "One Health" principle.
Among the strategies implemented by the State of Chile for the protection of the population's health is school vaccination, which began in 1949. Currently, this strategy includes vaccines that protect against pertussis, diphtheria and tetanus toxoids (Tdap), and Human Papillomavirus (HPV). This strategy is based on one of the most important public health premises, which consists of bringing health services closer to the target population to ensure more timely action and achieve higher vaccination coverage. This activity, free and universal, is carried out in all public and private educational institutions in the country. It is developed with the active participation of teachers and school authorities, as well as parents and guardians, which helps explain the success of this policy over the years and allows for high coverage in target groups. From the central level, the supporting documentation signed by authorities from both ministries is issued, and joint meetings are held with technical representatives from JUNJI, Integra, and the Ministry of Education. In addition, regional coordination between both representatives (SEREMI of Education/SEREMI of Health) and at the local level (public vaccination centers) with each school in their territory is essential to develop, according to regulations, on-site vaccination.
Conclusion
Chile has made significant progress in eliminating several communicable diseases, such as leprosy, human rabies transmitted by dogs, yaws, and vertical transmission of HIV, syphilis, and hepatitis B. These diseases have been subject to strict epidemiological surveillance and mandatory reporting, which has allowed the necessary indicators to be maintained to apply for elimination certification. The country is approaching elimination goals for other diseases, such as mother-to-child transmission of Chagas disease, cervical cancer, and viral hepatitis.
The Ministry of Health of Chile is implementing a National Health Strategy that includes a focus on communicable diseases with the goal of advancing towards their elimination by 2030. These efforts include intersectoral coordination under the "One Health" principle, expanding universal and targeted screenings, and integrating molecular testing to improve the detection and control of these diseases.
To continue making progress, Chile faces challenges in integrating health systems and services, strengthening health surveillance, and overcoming gaps in social and environmental determinants. It is essential to ensure the interoperability of information systems, keep regulations and plans updated, and ensure adequate funding for outbreak control and elimination.
Equity is a central principle in Chile's disease elimination strategy. Primary health care (PHC) is the foundation of these efforts, with a focus on ensuring equitable and universal access to health services, particularly in disadvantaged areas. Specific measures are being implemented to ensure coverage and access to essential services, including screening, diagnosis, and treatment programs.
Community and civil society participation is crucial in the disease elimination strategy. Specific initiatives, such as collaboration with foundations and community organizations, are in place to amplify efforts for disease prevention, control, and elimination. These partnerships are essential to strengthening the response to communicable diseases in the country.
Chile uses intersectoral coordination mechanisms, included in the National Health Strategy, to align efforts in the elimination of communicable diseases. School vaccination and the commitment of authorities to the prevention and treatment of individuals deprived of liberty are examples of these coordinated actions.
To achieve the elimination of communicable diseases by 2030, a **continuous and sustained commitment** from all stakeholders is vital. This includes strengthening health systems, allocating adequate resources, and fostering multisectoral collaboration. The Ministry of Health of Chile must lead this effort, ensuring service integration, equity in access to care, and active participation from the community and civil society.
It is imperative that all stakeholders come together in a coordinated effort to ensure that elimination goals are achieved and maintained, contributing to a healthier and more equitable future for all Chileans.
The Health Situation and Details of the Elimination Initiative Diseases
Summary of the Status of Diseases in the Elimination Initiative
Bacterial Meningitis
By 2023, the incidence of Meningococcal Disease (MD) is 0.3 cases per one hundred thousand inhabitants, while for other Bacterial Meningitis (BM) it is 1.7 cases per one hundred thousand inhabitants. In both groups, the highest risk of illness has been concentrated in children under 1 year old, with the highest rates: 19.8 per 100,000 inhabitants for BM and 6.3 per 100,000 inhabitants for MD in 2023. Chile has advanced in the elimination strategy, incorporating prevention against Haemophilus influenzae type b, pneumococcus, meningococcus serogroups A, C, Y, and W, and since 2023 against meningococcus serogroup B into its national vaccination plan. In 2012, an increase in MD cases occurred, and the last outbreak of the disease was reported in the country due to the resurgence of serogroup W. Additionally, there is a case-by-case surveillance system with immediate and universal notification, and quality management indicators related to access, timeliness, and quality of care are evaluated.
Cervical Cancer
The age-adjusted incidence rate of cervical cancer has remained stable between 2003 and 2020, with rates between 17.3 and 17.9 new cases per 100,000 women, respectively, according to the latest estimate from the Epidemiology Department, higher than the estimate from GLOBOCAN (11.3 new cases per 100,000 women, year 2022). Regarding survival, there was a slight increase of 0.5% at the fifth year post-diagnosis, increasing from 62.1% (2003-2010) to 62.5% (2010-2014). The most significant change has been observed in the cervical cancer mortality rate, which decreased between 2003 and 2021 from 7.6 to 4.8 deaths per 100,000 women.
Chagas Disease
Chile was certified as a country that interrupted vector transmission in 1999. Since then, there have been no cases of acute vector-borne Chagas, although sporadic imported cases have been reported. In 2021, two imported cases of vector-borne transmission from Bolivia were reported. Since this episode, no indigenous or imported cases of acute Chagas have been reported to date.
Cholera
Chile has remained free of autochthonous cholera (Vibrio cholerae O1 or O139) since 1998. This is due to the implementation of prevention and control actions, along with epidemiological surveillance of people and the environment, which have been maintained since the cholera outbreak that affected our country in 1991. The last autochthonous cases recorded in the country correspond to an outbreak in the Antofagasta region in late 1997 and early 1998. After this episode, imported cases from the Dominican Republic and Cuba occurred in 2011, 2013, and 2014, with no secondary cases in the country. Since 2015, no new toxigenic cases have been reported. In May 2024, an imported case was reported, requiring full sequencing analysis by the Public Health Institute. The result revealed Vibrio cholerae O1, Inaba serotype, El Tor biotype, with the absence of CTX toxin, unusual in Chile and the region, demonstrating the capacity for suspicion, timely diagnosis, and cholera ruling out, as in this case.
Congenital Chagas Disease
In Chile, vector transmission has been interrupted, as well as transfusion transmission through blood control in all blood banks in the country, and there is no evidence of oral transmission in the country. Therefore, mother-to-child transmission is the main source of Chagas disease cases.
Congenital Syphilis
Between 2018-2019, the congenital syphilis rate remained stable at 20 cases per 100,000 live births (LB), reaching the peak of the period in 2021 with 41.7 cases of congenital syphilis per 100,000 LB, then dropping in 2022 to 38.0 per 100,000 LB. It is noteworthy that in all the years of the 2018-2022 quinquennium, Chile maintained a congenital syphilis rate below the elimination target (<50 per 100,000 live births).
Cystic Echinococcosis / Hydatidosis
Hydatidosis is considered a neglected disease in the Americas region and a major public health problem in South America, and it is included in the Regional Program for its elimination for the 2020-2029 period. In Chile, from September 2017 to Epidemiological Week 28 of 2024, 1,622 confirmed cases have been reported. At the ministerial level, a technical working group has been established to address surveillance, prevention, and control aspects of the disease to meet the international elimination objective.
Fascioliasis
In Chile, it is not defined as a surveillance disease according to Supreme Decree N°7/2019, which approves the regulation on the notification of mandatory reportable communicable diseases.
Hepatitis B and C
Since 2018 (8.1 per 100,000 inhabitants), there has been a decrease in hepatitis B confirmation rates, stabilizing between 2020-2022 at approximately 4 cases per 100,000 inhabitants, showing a ratio of 2.7 men for every woman in 2022. In the 2018-2022 quinquennium, hepatitis C confirmation rates stabilized at 2.7 per 100,000 inhabitants. In 2022, men showed a 27% increase in their rate compared to 2021, particularly shifting to younger ages, with the highest rates between 30 and 39 years. In 2022, the ratio was 3.6 men for every woman.
Mother-to-Child Transmission of Hepatitis B (HBV-MTCT)
No cases of vertical transmission of hepatitis B have occurred in the country in the last five years. In Chile, there is a standard for preventing the vertical transmission of hepatitis B.
Mother-to-Child Transmission of HIV (HIV-MTCT)
Between 2018-2022, the population rate of vertical HIV transmission experienced a steady decline from 0.04 cases per 1,000 live births in 2018 to 0.02 cases per 1,000 live births in 2022, maintaining a vertical transmission rate below the elimination target (<0.5 per 1,000 live births). Additionally, in 2022, the country had a mother-to-child transmission rate (percentage of children with HIV from the total number of children born to mothers diagnosed with HIV) of 1.5%, which is below the elimination target (<2%).
HIV/AIDS
In 2022, it was estimated that 4,800 new HIV infections occurred in the country, with a rate of 24.2 per 100,000 inhabitants. The age-adjusted AIDS mortality rate in 2021 was 2.4 per 100,000 inhabitants (using Chile's 2017 population as a reference). It should be noted that during the period 2000-2021, this indicator decreased by 25%.
Rabies transmitted by dogs
From 1996 to date, there have been two cases of human rabies in Chile. The first occurred in 1996, caused by the bat variant (V4). The second case survived the infection and occurred in 2013; the virus could not be isolated, but during the epidemiological investigation, the same variant was also suspected.
Leprosy
In Chile, there have been no autochthonous cases of leprosy, meaning people who have acquired this disease within the national territory, since 1993.
Lymphatic Filariasis
In Chile, it is not defined as a surveillance disease according to Supreme Decree N°7/2019, which approves the regulation on the notification of mandatory reportable communicable diseases.
Malaria
In Chile, the disease has not been endemic for decades. In 1936, approximately 50% of the population in the regions of Arica and Parinacota and Tarapacá was affected, which prompted the malaria campaign at the time, establishing anti-malarial stations in the port of Arica, with a primary focus on vector control actions in all affected sectors and the treatment of infected individuals. These actions eliminated the disease from the country, with no indigenous cases recorded since 1945, although the mosquito vector is still present in both regions. In 2023, six imported cases were confirmed, all related to travel to Venezuela, Colombia, Bolivia, and Brazil.
Chile has been certified by the WHO since 1968 as a malaria-free country, within the category of "Countries where malaria never existed or disappeared without specific measures."
Onchocerciasis, Schistosomiasis, Soil-Transmitted Helminthiasis, and Trachoma
These diseases do not have a surveillance system according to Supreme Decree N°7/2019.
Plague
There have been no cases of plague in Chile since the 1940s.
Tuberculosis[1]
In Chile, in 2023, the incidence rate of tuberculosis in all its forms (including new cases and relapses) was 15.8 cases per 100,000 inhabitants, representing an annual increase of 8.9%. The number of new tuberculosis cases in that year was 2,973, while relapses were 177. In 2023, 81.8% of tuberculosis cases were pulmonary forms, and 18.2% were extrapulmonary. The incidence rate in men is 20.4 per 100,000 inhabitants compared to the rate in women, which is 11.3 per 100,000 inhabitants, meaning the male population has a rate 1.8 times higher than the female population. In the population under 15 years old, 111 cases were recorded in 2023, representing an annual increase of 26.1%. The mortality rate from tuberculosis in all its forms for 2023 was 1.26 per 100,000 inhabitants, increasing by 0.01 points compared to 2022. This figure corresponded to 251 people who died from tuberculosis in the country, 4 more than the previous year.
Measles
Chile interrupted endemic virus transmission in 1993. Subsequently, isolated cases or sporadic outbreaks occurred in 2003, 2009, 2011, and 2015. Between late 2018 and January 2020, a total of 36 measles cases were confirmed in Chile. Cases occurred mainly from late 2018 to early 2020, generating 23, 11, and 2 cases per year, respectively. All were imported cases from countries in the Region and some from Europe, and only one of the 2018 cases generated a significant outbreak associated with importation, affecting children under 1 year old. During 2021 and 2022, no cases were reported. In August 2023, the last imported case of measles was confirmed, with a history of travel to endemic areas with active outbreaks, which did not generate secondary cases. In 2024, no new confirmed cases have been reported. Chile is in the process of reverification by the International Expert Committee for the interruption of endemic measles, rubella, and CRS.
PAHO/WHO certified the elimination in Chile in 2016.
Neonatal Tetanus
The last case of neonatal tetanus in Chile occurred in 1996.
Poliomyelitis
In Chile, the last case of poliomyelitis caused by wild poliovirus occurred in 1975. This is due to global efforts to advance eradication, which resulted in: a) Optimal vaccination coverage and strengthening of the National Immunization Program (PNI); b) Syndromic surveillance of Acute Flaccid Paralysis (AFP), the main mechanism for detecting poliomyelitis cases; and c) National reference laboratory (NRL) for poliovirus diagnosis, which is part of the global poliovirus diagnostic network. Chile maintains its polio eradication status, evaluated by the International Expert Committee. The Region of the Americas registered its last poliomyelitis case in 1991, and in 1994, it became the first region in the world to receive WHO certification as free of the disease.
Rubella
In Chile in 2007, a rubella outbreak occurred, mainly affecting young men. This group had not been included in the 1999 vaccination campaign, which was aimed solely at women. As a control measure and with the goal of eliminating rubella, a second vaccination campaign was conducted in 2007, targeting men aged 19 to 29. This campaign achieved 92% coverage. By mid-2008, endemic rubella virus transmission in the country was interrupted. Subsequently, imported cases occurred in 2008, 2011, and 2019. Chile is in the process of reverification by the International Expert Committee for the interruption of endemic measles, rubella, and Congenital Rubella Syndrome (CRS). PAHO certified rubella elimination in 2015.
Congenital Rubella
The last case of CRS was in 2009. However, CRS and TORCH (toxoplasmosis, other infections, rubella, cytomegalovirus, herpes simplex virus) surveillance continues. A retrospective search for specific ICD-10 codes for congenital malformations associated with congenital rubella is currently being carried out to reinforce surveillance. Chile is in the process of reverification by the International Expert Committee for the interruption of endemic measles, rubella, and CRS.
Yellow Fever
Chile is free from yellow fever circulation. The last imported case was reported in 2017. In areas with the presence of the vector (Easter Island, Arica, Iquique, Aconcagua), no indigenous cases have been reported.
[1] Information provided by Tuberculosis Program references, DIPRECE.
The sources of the interagency indicators used in this profile can be found in this table.
For the latest data on health indicators for the Region of the Americas, be sure to visit the PAHO Core Indicators portal.
Country COVID-19 Persperctive
Measures to achieve universal health coverage
The current government, whose term began in 2022, established in its plan the determination to move towards a universal and unified health system, bringing greater equity in health care for all the country's inhabitants. Specifically, the measures embodied in the plan include creating a universal health fund to ensure the financial sustainability of the health system, along with access to health care when needed; strengthening the national health system to improve the quality and timeliness of public health care services; extending universal primary health care to the entire population; developing a digital health strategy; financing investments for health infrastructure and equipment, and for free access to certain medicines; creating a national observatory to monitor efforts to reduce gaps in human resources for health; addressing the need for an intercultural approach to health; and prioritizing comprehensive cancer and mental health care.
Challenges related to population health
Today, Chile's main challenge is to reach an agreement, within the framework of reforming the Chilean Constitution, on a vision of a health system that meets the country’s needs, while promoting the transformations necessary to make that approach progressive and sustainable. The proposal for reforming the Constitution, which was submitted to a public plebiscite in September 2022, enshrines the right to health and the existence of a universal, public, and integrated State-controlled national health system. Such a health system should respect the principles of equity, solidarity, interculturality, territorial relevance, decentralization, efficiency, quality, timeliness, a gender approach, progressivity, and non-discrimination. The proposal also envisages that the funds for financing this health system should come from nation’s general revenues and from mandatory solidarity contributions.
In the end, the plebiscite rejected the proposed text of the new constitution and, as of the time of this report, a public debate on implementation of a new constitutional process is underway. The government is proposing to implement the reforms pursuant to the new constitutional mandate, and includes in its government program, among other reforms, the creation of a unified health fund.
Measures to reduce inequalities in health
Public policies are focused on reducing inequalities, through a cross-cutting approach that encompasses various dimensions. In terms of income, for example, two initiatives have been proposed: increasing the minimum wage and creating a universal basic pooled pension for older people.
Another important factor for reducing inequalities between the various population groups concerns the territorialization approach and regionalization process, involving the transfer of competencies and financing to regional governments, in areas such as transport and mobility, as well as digital infrastructure and internet access.
National strategy to address inequalities in health
Reducing inequities and inequalities in health encompasses all objectives of the national strategy, in a cross-cutting and comprehensive manner. Equity is therefore a key axis of all of the policies prioritized in the National Health Strategy 2021–2030. Through a cross-cutting approach, each health service provided, and each prioritized policy and/or strategy will come with guaranteed improvements in access, timeliness, and quality of health care.
The sources of the interagency indicators used in this profile can be found in this table.
For the latest data on health indicators for the Region of the Americas, be sure to visit the PAHO Core Indicators portal.
COUNTRY/TERRITORY PROFILES
Anguilla
Antigua and Barbuda
Argentina
Aruba
Bahamas
Barbados
Belize
Bermuda
Bolivia
Bonaire, Sint Eustatius, and Saba
Brazil (English) (Português)
Canada
Cayman Islands
Chile
Colombia
Costa Rica
Cuba
Curaçao
Dominica
Dominican Republic
Ecuador
El Salvador
French Guiana, Guadeloupe and Martinique
Grenada
Guatemala
Guyana
Haiti (English) (Français)
Honduras
Jamaica
Mexico
Montserrat
Nicaragua
Panama
Paraguay
Peru
Puerto Rico
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Sint Maarten
Suriname
Trinidad and Tobago
Turks and Caicos Islands
United States of America
Uruguay
Venezuela
Virgin Islands (British)
Virgin Islands (U.S.)